Persistent URL of this record https://hdl.handle.net/1887/73954
Documents
-
- Download
- Weerdt_et_al_2018_T
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Improving CLL Vg9Vd2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib
- All authors
- Weerdt, I. de; Hofland, T.; Lameris, R; Endstra, S.; Jongejan, A.; Moerland, P.D.; Bruin, R.C.G. de; emmerswaal, E.B.M.; Berge, I.J.M. ten; Liu, N.; Stelt, M. van der; Faber, L.M.; Levin, M.D.; Eldering, E.; Tonino, S.H.; Gruijl, T.D. de; Vliet, H.J. van der; Kater, A.P.
- Date
- 2018-11-22
- Journal
- Blood
- Volume
- 132
- Issue
- 21
- Pages
- 2260 - 2272